全文获取类型
收费全文 | 1332689篇 |
免费 | 114889篇 |
国内免费 | 6621篇 |
专业分类
耳鼻咽喉 | 16700篇 |
儿科学 | 42932篇 |
妇产科学 | 36592篇 |
基础医学 | 182856篇 |
口腔科学 | 36320篇 |
临床医学 | 120514篇 |
内科学 | 276883篇 |
皮肤病学 | 31877篇 |
神经病学 | 109952篇 |
特种医学 | 55610篇 |
外国民族医学 | 281篇 |
外科学 | 210163篇 |
综合类 | 32065篇 |
现状与发展 | 3篇 |
一般理论 | 414篇 |
预防医学 | 106071篇 |
眼科学 | 28097篇 |
药学 | 93824篇 |
5篇 | |
中国医学 | 2311篇 |
肿瘤学 | 70729篇 |
出版年
2018年 | 13482篇 |
2017年 | 10740篇 |
2016年 | 12890篇 |
2015年 | 14460篇 |
2014年 | 20145篇 |
2013年 | 29913篇 |
2012年 | 36518篇 |
2011年 | 39165篇 |
2010年 | 24524篇 |
2009年 | 24024篇 |
2008年 | 36543篇 |
2007年 | 38939篇 |
2006年 | 40067篇 |
2005年 | 38693篇 |
2004年 | 36840篇 |
2003年 | 35891篇 |
2002年 | 33855篇 |
2001年 | 66027篇 |
2000年 | 67833篇 |
1999年 | 56355篇 |
1998年 | 16043篇 |
1997年 | 14273篇 |
1996年 | 15260篇 |
1995年 | 16191篇 |
1994年 | 15072篇 |
1993年 | 14099篇 |
1992年 | 47058篇 |
1991年 | 45767篇 |
1990年 | 43963篇 |
1989年 | 41808篇 |
1988年 | 38732篇 |
1987年 | 38063篇 |
1986年 | 35841篇 |
1985年 | 34622篇 |
1984年 | 26335篇 |
1983年 | 22069篇 |
1982年 | 13812篇 |
1981年 | 12414篇 |
1980年 | 11666篇 |
1979年 | 23512篇 |
1978年 | 17023篇 |
1977年 | 14337篇 |
1976年 | 13142篇 |
1975年 | 13694篇 |
1974年 | 16068篇 |
1973年 | 15380篇 |
1972年 | 14167篇 |
1971年 | 13025篇 |
1970年 | 11863篇 |
1969年 | 11092篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Sibylle M. Winter Katja Dittrich Peggy Dörr Judith Overfeld Imke Moebus Elena Murray Gergana Karaboycheva Christian Zimmermann Andrea Knop Manuel Voelkle Sonja Entringer Claudia Buss John-Dylan Haynes Elisabeth B. Binder Christine Heim 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(9):1027-1045
12.
Yevdulov O. V. Yevdulov D. V. Isabekova T. I. Aminov G. I. Aminova I. Yu. 《Biomedical engineering》2022,56(2):146-150
Biomedical Engineering - A mathematical model of a thermoelectric device for the treatment of whitlow by local hypothermia is discussed. The model is based on a solution of the heat conduction task... 相似文献
13.
14.
- DNA is the sequence that codes for proteins.
- Messenger RNA is transcribed from the DNA sequence of genes and translated into protein.
- It can be difficult to predict how a change in the DNA sequence will affect messenger RNA and protein quantity and quality.
- DNA translocation changes can cause the joining of sequences from two different genes or different parts of the same gene.
- DNA sequencing is often used clinically to predict how DNA changes might affect proteins.
- Alternatively, RNA sequencing can be used as a more direct measure of the effect of DNA changes on the protein products.
- This sequencing is important for identifying changes in cancer that may indicate response to targeted therapy, prognosis, or diagnosis.
15.
16.
Koji Sasaki Tapan Kadia Kebede Begna Courtney D. DiNardo Gautam Borthakur Nicholas J. Short Nitin Jain Naval Daver Elias Jabbour Guillermo Garcia-Manero Guillermo Montalban Bravo Lucia Masarova Sherry Pierce Marina Konopleva Farhad Ravandi Ayalew Tefferi Hagop Kantarjian 《American journal of hematology》2022,97(1):68-78
The progress with intensive chemotherapy and supportive care measures has improved survival in patients with newly diagnosed acute myeloid leukemia (AML). Given the recent development of effective low intensity therapies, an optimal decision on the therapy intensity may improve survival through the avoidance of early mortality. We reviewed the outcome of 3728 patients with newly diagnosed AML who received intensive chemotherapy between August 1980 and May 2020. Intensive chemotherapy was defined as a cumulative cytarabine dose ≥ 700 mg/m2 during induction therapy. We divided the whole cohort into a training and validation group at a 3:1 ratio. The population was divided into a training (2790 patients) and a validation cohort (938 patients). The median age was 55 years (range, 15-99). Among them, 442 patients (12%) had core-binding factor AML. Binary logistic regression identified older age, worse performance status, hyperbilirubinemia, elevated creatinine, hyperuricemia, cytogenetic abnormalities other than CBF and -Y, and pneumonia as adverse prognostic factors for an early 4-week mortality. This risk classification for early mortality was verified in the validation cohort of patients. In the validation cohort of more recently treated patients from 2000 to 2017, the 4-week mortality rates with intensive chemotherapy were 2%, 14%, and 50% in the low-, high-, and very high-risk group, respectively. The mortality rates with low intensity therapies were 3%, 9%, and 20%, respectively. The risk classification guides treatment intensity by the assessment of age, frailty, organ dysfunction, cytogenetic abnormality, and infection to avoid early mortality. 相似文献
17.
18.
Stephanie H. Ameis John D. Haltigan Rachael E. Lyon Amanda Sawyer Pat Mirenda Connor M. Kerns Isabel M. Smith Tracy Vaillancourt Joanne Volden Charlotte Waddell Lonnie Zwaigenbaum Teresa Bennett Eric Duku Mayada Elsabbagh Stelios Georgiades Wendy J. Ungar Anat Zaidman-Zait Meng-Chuan Lai Peter Szatmari for the Pathways in ASD Study Team 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(5):553-562
19.
20.
Loren Saulsberry PhD Ankur Bhargava MD MPH Sharon Zeng BA Jason B. Gibbons PhD Cody Brannan MS Diane S. Lauderdale PhD Robert D. Gibbons PhD 《Health services research》2023,58(4):873-881